The register. Tell me how many registers have 80% in the Top 20.
The potential and growing market for dengue
The fact it is repurposed so a lot of the safety testing was done and derisked.
The fact that the Monash study has some pretty compelling data.
The fact that the US military is involved and paying for a part of the Phase IIa study?
I think you need to read a little.. Go and tick those boxes with other pharma startups on ASX.
- Forums
- ASX - By Stock
- ILA
- Ann: Grant funding to directly support Phase 2a trial
Ann: Grant funding to directly support Phase 2a trial, page-34
Featured News
Add ILA (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
0.040(33.3%) |
Mkt cap ! $24.94M |
Open | High | Low | Value | Volume |
13.5¢ | 16.0¢ | 13.0¢ | $66.90K | 472.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 245030 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 245030 | 0.140 |
1 | 8000 | 0.135 |
2 | 40660 | 0.130 |
1 | 9480 | 0.125 |
2 | 17905 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 25000 | 1 |
0.190 | 56048 | 2 |
0.195 | 300000 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ILA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online